Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGR
1926
DELISTED
Avangrid, Inc.
AGR
| $3.47M | ﹤0.01% |
81,100
+27,600
| +52% | +$1.13M |
|
|
FRBK
1927
DELISTED
Republic First Bancorp Inc
FRBK
| $3.46M | ﹤0.01% |
417,439
-210,961
| -34% | -$1.67M |
|
|
ACHN
1928
DELISTED
Achillion Pharmaceuticals
ACHN
| $3.45M | ﹤0.01% |
819,900
-125,289
| -13% | -$520K |
|
1929
Marchex
MCHX
$80.6M
| $3.45M | ﹤0.01% |
1,267,242
+86,841
| +7% | +$234K |
|
1930
Lamb Weston
LW
$7.39B
| $3.44M | ﹤0.01% |
+81,800
| New | +$3.23M |
|
|
TPCO
1931
DELISTED
Tribune Publishing Company Common Stock
TPCO
| $3.44M | ﹤0.01% |
247,100
+54,400
| +28% | +$746K |
|
|
PTHN
1932
DELISTED
Patheon N.V.
PTHN
| $3.44M | ﹤0.01% |
+130,500
| New | +$3.82M |
|
|
GNC
1933
DELISTED
GNC Holdings, Inc.
GNC
| $3.44M | ﹤0.01% |
466,895
-289,205
| -38% | -$2.49M |
|
|
MIXT
1934
DELISTED
MIX TELEMATICS LIMITED
MIXT
| $3.42M | ﹤0.01% |
543,510
+189,710
| +54% | +$1.33M |
|
|
TIVO
1935
DELISTED
Tivo Inc
TIVO
| $3.42M | ﹤0.01% |
182,235
-422,138
| -70% | -$8.07M |
|
|
DVAX
1936
DELISTED
Dynavax Technologies
DVAX
| $3.42M | ﹤0.01% |
574,051
+110,100
| +24% | +$529K |
|
|
PEI
1937
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
| $3.42M | ﹤0.01% |
15,040
-51,380
| -77% | -$13M |
|
|
PWOD
1938
DELISTED
Penns Woods Bancorp
PWOD
| $3.41M | ﹤0.01% |
117,750
+12,750
| +12% | +$399K |
|
|
CHUY
1939
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $3.39M | ﹤0.01% |
+113,815
| New | +$3.33M |
|
|
EGAS
1940
DELISTED
Gas Natural Inc.
EGAS
| $3.38M | ﹤0.01% |
266,500
-77,500
| -23% | -$980K |
|
1941
Fortis
FTS
$28.8B
| $3.38M | ﹤0.01% |
102,000
+78,600
| +336% | +$2.51M |
|
|
RBS.PRH.CL
1942
DELISTED
Royal Bank Of Scotland Group
RBS.PRH.CL
| $3.38M | ﹤0.01% |
131,388
-36,021
| -22% | -$927K |
|
1943
Embotelladora Andina Series A
AKO.A
$3.75B
| $3.37M | ﹤0.01% |
149,800
+300
| +0.2% | +$6.34K |
|
|
CSLT
1944
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $3.37M | ﹤0.01% |
922,800
+20,610
| +2% | +$72.4K |
|
1945
Red Rock Resorts
RRR
$3.67B
| $3.37M | ﹤0.01% |
+151,800
| New | +$3.47M |
|
|
DISCK
1946
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $3.37M | ﹤0.01% |
+118,850
| New | +$3.26M |
|
|
PBFX
1947
DELISTED
PBF LOGISTICS LP
PBFX
| $3.36M | ﹤0.01% |
156,117
+6,785
| +5% | +$139K |
|
|
DX
1948
Dynex Capital
DX
$3.23B
| $3.35M | ﹤0.01% |
157,600
+36,593
| +30% | +$748K |
|
1949
T. Rowe Price
TROW
$23.7B
| $3.35M | ﹤0.01% |
+49,191
| New | +$3.49M |
|
|
CHCT
1950
Community Healthcare Trust
CHCT
$433M
| $3.35M | ﹤0.01% |
140,000
+20,000
| +17% | +$457K |
|
Similar funds
Jim Simons's Q1 2017 Portfolio in Review
As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Jim Simons opened 433 new positions and closed 462 in Q1 2017.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.